Karl-Frederick Karstens
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 23, 2024
A Comprehensive Analysis of Tn and STn Antigen Expression in Esophageal Adenocarcinoma.Baris Mercanoglu, Karl-Frederick Karstens, Anastasios D Giannou
|Feb 25, 2022
Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma.Björn-Ole Stüben, Jakob Stuhlfelder, Marius Kemper
|Jan 05, 2021
Oesophageal Adenocarcinomas: Where Do We Stand Today?Karl-Frederick Karstens, Björn Ole Stüben, Matthias Reeh
|Apr 17, 2020
Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomas.Karl-Frederick Karstens, Jan Kempski, Anastasios D Giannou
|Aug 03, 2019
Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).Jenny Hötzel, Nathaniel Melling, Julia Müller
Pageof 1
